Literature DB >> 22801129

Video-assisted resection in mediofacial lateral tumors.

Jorge Orlando Guerrissi1.   

Abstract

Tumors that developed into the soft tissues of the cheek rising from the anterior prolongation of the parotid gland, minor salivary glands, and the masseter muscle are the most profitable with the use of video-assisted surgery.In the Department of Plastic Surgery at Argerich Hospital in Buenos Aires, Argentina, from 1999 to 2010, video-assisted approaches were used in the treatment of 158 patients, 16 of them presented tumors that developed into the tissues of the cheek.Intraoral approach such as natural orifice surgery was performed in 13 cases; in the other 3 cases, a preauricular incision was performed. Minor complications such as hematoma and transitory paresis of the superior buccal nerve were detected.Video-assisted technique offers both good illumination and excellent magnification, permitting not only a safe anatomic dissection by means of surgical maneuvers in avascular planes but also contributed to avoid injuries of facial nerve branches and secondary obstruction of the Stensen duct. On the other hand, when intraoral incisions are used, visible scarring is avoided; the uses of transoral areas are the most feasible approaches of natural orifice surgery.The outcome achieved with endoscopic techniques in mediofacial lateral areas has permitted to consider it as the first election in the surgical treatment in tumors that developed into the soft tissues of the cheek, offering more advantages than the classic approaches.

Entities:  

Mesh:

Year:  2012        PMID: 22801129     DOI: 10.1097/SCS.0b013e31824e26b6

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  1 in total

1.  Endoscope-assisted resection of nonneoplastic space-occupying lesion in oral and maxillofacial areas.

Authors:  Yanan Li; Runqi Xue; Qingguo Lai; Bingbing Xu; Kuifeng Yuan; Xiaopeng Tang; Jiangbo Ci; Shaolong Sun; Zhichao Zhang
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.